Background: In eukaryotic cells, detection of replication stress results in the activation of the DNA replication checkpoint, a signaling cascade whose central players are the kinases ATR and Chk1. The checkpoint response prevents the accumulation of DNA damage and ensures cell viability by delaying progression into mitosis. However, the role and mechanism of the replication checkpoint transcriptional response in human cells, which is p53 independent, is largely unknown. Results: We show that, in response to DNA replication stress, the regular E2F-dependent cell-cycle transcriptional program is maintained at high levels, and we establish the mechanisms governing such transcriptional upregulation. E2F6, a repressor of E2F-dependent G1/S transcription, replaces the activating E2Fs at promoters to repress transcription in cells progressing into S phase in unperturbed conditions. After replication stress, the checkpoint kinase Chk1 phosphorylates E2F6, leading to its dissociation from promoters. This promotes E2F-dependent transcription, which mediates cell survival by preventing DNA damage and cell death. Conclusions: This work reveals, for the first time, that the regular cell-cycle transcriptional program is part of the DNA replication checkpoint response in human cells and establishes the molecular mechanism involved. We show that maintaining high levels of G1/S cell-cycle transcription in response to replication stress contributes to two key functions of the DNA replication checkpoint response, namely, preventing genomic instability and cell death. Given the critical role of replication stress in oncogene transformation, a detailed understanding of the molecular mechanisms involved in the checkpoint response will contribute to a better insight into cancer development.
Introduction
To properly replicate the genome and prevent genomic instability, cells rely on the DNA integrity checkpoints, an evolutionarily conserved set of signaling pathways that constantly monitor for the loss of integrity of the DNA replication fork or DNA damage. The DNA integrity checkpoints are mediated by the evolutionarily conserved protein kinases ATM/ATR, acting through Chk1 and Chk2 [1] [2] [3] . These protein kinases transduce the checkpoint signal to the cell-cycle and transcriptional machinery by phosphorylating protein targets [4] . The DNA replication and DNA damage checkpoints ensure that DNA has been fully replicated and that damage has been repaired before division [5] . The fundamental difference between the two checkpoints is that the DNA replication checkpoint is essential for preventing DNA damage in response to replication stress during S phase, whereas the DNA damage checkpoint is required to detect and resolve DNA damage before entry into mitosis. Whereas both checkpoints delay progression into mitosis via largely overlapping mechanisms, they induce similar but distinct transcriptional responses [6] . The differences in mechanism and expression program are poorly established but are thought to reflect the intrinsically different aims of the replication and damage checkpoints, to prevent DNA damage or resolve DNA damage, respectively.
During DNA replication, cells are particularly vulnerable to genomic instability as replication forks are prone to stall and collapse when encountering replication blocks or damaged DNA templates [1, 7] . Replication stress is also a consequence of oncogene activation. A recent model of oncogenesis proposes that, after oncogene-induced replication stress, DNA damage ensues, which can lead to a number of mutations in key tumor suppressors, like TP53, and genomic instability [8] . It is therefore crucial to understand the cellular response to replication stress and its role in preventing the occurrence of DNA damage. The DNA replication checkpoint depends mainly on ATR and the downstream checkpoint protein kinase Chk1, although there is some degree of crosstalk with the DNA damage checkpoint protein kinases ATM and Chk2 [2] . After phosphorylation by ATR, Chk1 becomes active and is released from chromatin to phosphorylate its substrates [9] , which include cell-cycle regulators, most notably Cdc25 [10] , and proteins involved in DNA repair, including Rad51 [11] .
Whereas the main regulator of DNA-damage-inducible genes in G1 is the transcription factor p53, a target of both ATM and Chk2 [12] , the molecular details of the largely p53-independent transcriptional response to replication stress have not been established [13] . Genome-wide expression analysis carried out in this study reveals that the G1/S cellcycle transcriptional program is regulated as part of the DNA replication checkpoint response in human cells. In mammalian cells, G1/S transcriptional regulation depends on the E2F family of transcription factors (E2F1-E2F8) and their regulators, the pocket protein family members (pRb, p107, and p130), which are well-established tumor suppressors (reviewed in [14] [15] [16] [17] ). Previous works established a proapoptotic role for the activator E2F, E2F1, after DNA damage checkpoint activation [18] [19] [20] [21] . However, this is independent of its role in the cellcycle transcriptional program. Here we report a role for the E2F-dependent cell-cycle transcriptional program in the DNA replication checkpoint response in human cells. We establish the mechanism by which the G1/S transcriptional program is rewired by the DNA replication checkpoint and show that this regulation is required to cope with replication stress and avoid genomic instability and cell death. Our study highlights the inherent difference between the DNA replication and DNA damage checkpoint responses, showing an intrinsically different role for E2F-dependent transcription in response to DNA replication stress: promotion of genome stability and survival rather than cell death.
Results
Replication Stress Induces E2F-Dependent Cell-Cycle Transcripts In order to investigate the DNA replication checkpoint transcriptional response, we analyzed the genome-wide expression profile of S phase cells with and without replication stress induced by hydroxyurea (HU) treatment. HU, an inhibitor of ribonucleotide reductase, causes nucleotide depletion and is widely used to induce replication stress [22, 23] . It causes replication fork stalling after DNA replication origins have been licensed and fired, resulting in the activation of the checkpoint protein kinase ATR and its downstream target Chk1, inducing an intra S phase arrest. Potential cell-cycle positioning differences after replication stress were avoided through the use of synchronized human T98G cells. Serumstarved cells were released in serum for 16 hr (G1/S), at which point cells were either treated with HU for 4 hr (20 hr HU) or left untreated for 4 hr (20 hr untreated; experimental design is represented in Figure S1A available online). The short treatment with HU during S phase induces DNA replication checkpoint activation, as detected by S345 phosphorylation of Chk1 ( Figure S1B ). Importantly, it does not induce significant DNA damage, as shown by the low levels of gamma-H2AX compared to the levels induced by the DNA damaging agent camptothecin (CPT) at the same time points. Together, these data show that our experimental setup allows for specific activation of the DNA replication checkpoint without causing significant DNA damage and possible DNA damage checkpoint activation.
Expression profiles were established by microarray for untreated and HU-treated samples. Comparison of expression levels resulted in a list of 846 genes significantly upregulated in response to HU treatment (Table S1 ). Gene ontology analysis of these revealed that the top enriched ontology categories include the DNA replication, DNA repair, and cell-cycle groups (Table 1 ). Since these groups of genes are mainly regulated during the G1-to-S transition of the cell cycle by the E2F transcription factors, we investigated whether there was an enrichment of E2F target genes among the HU-responsive gene list. A list of 459 cell-cycle-regulated E2F targets from previous studies was compiled (Table S2) [24] [25] [26] [27] . We find significant enrichment of E2F targets in the HU-induced gene list (p = 0.035; Figures S1C and S1D and Table S3 ), suggesting that E2F-dependent cell-cycle transcription could be part of the replication stress checkpoint transcriptional response.
To confirm and extend the genome-wide expression analysis, we carried out single gene expression analysis on a set of well-established G1/S E2F targets using quantitative PCR (qPCR). These data show that the well-established G1/S E2F targets are significantly upregulated during S phase in response to replication stress ( Figure 1A ).
E2F-Dependent Cell-Cycle Transcription Is Induced in
Response to Replication Stress in a Chk1-Dependent Manner To establish the dynamics of E2F-dependent cell-cycle transcriptional regulation in response to replication stress, we carried out expression analysis in both synchronized (Figures 1B and S1E) and asynchronous cells ( Figure S1G ). Expression levels of the well-established E2F G1/S cell-cycle targets cyclin E, RRM2, and CDC6 reveal that while transcription is inactivated in a timely manner in untreated cell cultures, these transcripts remain active after HU treatment. Similar results were obtained with thymidine-induced replication block in T98G cells ( Figure S1F ) and in a primary human cell line treated with HU ( Figure S1H ). In agreement with the transcriptional data, the protein levels of cyclin E and E2F1 remain high upon HU treatment ( Figure 1C ), while in control cells they peak at 18-20 hr and then decrease during cell-cycle progression, as expected.
Since HU treatment causes an intra-S-phase arrest through Chk1 activation [22, 23, 28] , we tested whether the transcriptional response of E2F targets is Chk1 dependent. Chemical inhibition of Chk1 function by UCN01 treatment shows that derepression of G1/S transcripts and protein accumulation of E2F targets in response to HU treatment is Chk1 dependent (Figures 1B and 1C) . Similar results were obtained with small interfering RNA (siRNA) targeting Chk1 ( Figure S1I ). Altogether, these results show that E2F-dependent G1/S transcription is maintained at high levels in response to replication stress via a Chk1-dependent mechanism.
The Transcriptional Repressor E2F6 Binds to E2F-Regulated Promoters to Inhibit G1/S Transcription Next we sought to establish the mechanism by which the checkpoint interferes with G1/S transcription. We hypothesized that the checkpoint could target a transcriptional repressor normally involved in turning off G1/S transcription during S phase. A role for E2F6 in timely inactivation of E2F targets during S phase has been suggested [29] . However, these studies, carried out in E2F6 knockout mouse fibroblasts, were inconclusive, likely due to a compensatory role of E2F4 [29] . To establish whether E2F6 could be involved in turning off transcription during S phase, we first established the binding of E2F transcription factors to their target genes during the cell cycle. We carried out a cell-cycle time course of chromatin immunoprecipitations (ChIP) using antibodies to E2F4, E2F6, and, as a representative activator E2F, E2F1.
E2F target promoters are mainly occupied by E2F4 in quiescence (Figure 2A ), as previously reported [30] . Upon release into the cell cycle, E2F4 is replaced by E2F1, correlating with transcriptional activation, which, in turn, is replaced by E2F6 once cells progress into S phase. E2F6 recruitment to promoters starts at G1/S and peaks in S phase, when E2F1 is released, correlating with transcriptional repression, while E2F4 does not appear to be significantly recruited at this point ( Figure 2A ). To determine whether E2F6 plays a role in turning off G1/S transcription, we analyzed RNA and protein levels of See also Figure S1 and Table S1 .
E2F targets in synchronized cells in which E2F6 had been depleted. We observe that acute loss of E2F6, by siRNA knockdown, leads to a persistently high level of G1/S transcription, relative to control transfected cells. This supports a role for E2F6 in the repression of E2F targets upon exit from G1 phase ( Figures 2B and S2A ). Transcriptional derepression is also reflected in the sustained high levels of E2F-regulated proteins in the absence of E2F6 ( Figures S2B and S2C ). Whereas in control cells these proteins peak at the G1-to-S transition and then decrease with cell-cycle progression, in E2F6-depleted cells they remain high. Collectively, these data suggest that E2F6 plays an important role in repressing G1/S transcription during G1 and S phases.
E2F6 Repressive Function Is Inhibited in Response to
Replication Stress E2F6's function positions it as a potential target via which the replication checkpoint protein kinase Chk1 could keep E2F-regulated G1/S transcription active. If inhibition of E2F6 function is part of the DNA replication checkpoint response, the expression profile of HU-treated and E2F6-depleted cells should significantly overlap. Genome-wide expression See also Figure S1 , Table S1 , Table S2, and  Table S3 .
analysis using bead microarrays of synchronized S phase cells either transfected with siE2F6 or control siRNA identified more than 700 targets as significantly induced after E2F6 depletion (Table S4) . Gene ontology analysis revealed enrichment for similar categories upon HU treatment, among which the most represented were the DNA replication and repair and cell-cycle groups (Table S5) . Importantly, there is a significant overlap (p < 10 24 ) between the ''siE2F6-upregulated genes'' and ''HU-upregulated genes'' ( Figure S3 and Table S6 ), indicating that a common gene set is regulated by E2F6 and in response to replication stress.
To confirm and extend our genome-wide expression analysis, we tested whether the E2F cell-cycle targets induced in response to replication stress ( Figure 1A ) depend on E2F6 for their repression during S phase. These data show that all of the 14 well-established E2F-dependent G1/S targets significantly upregulated in response to HU are also upregulated in response to E2F6 depletion ( Figure 3A) , suggesting that the replication checkpoint could inhibit E2F6-dependent repression.
We reasoned that one way of inhibiting E2F6 function in response to replication stress is via affecting its ability to bind, and repress, E2F target promoters. To test this, we fixed synchronized T98G cells at the indicated time points and analyzed the binding of E2F6 and E2F1 at two well-established E2F target promoters by ChIP. While E2F6 is recruited to these promoters when cells enter S phase (20 hr), this recruitment is significantly reduced in cells treated with HU ( Figures 3B and  S4A) . Furthermore, the reduced recruitment of E2F6 to these promoters in response to HU treatment correlates with an enhanced binding of E2F1 compared to untreated cells. This suggests that E2F6 binding to promoters is impaired in response to nucleotide depletion.
Chk1 Regulates E2F6 through Direct Phosphorylation
Overall, these data indicate that E2F6 could be a direct substrate of Chk1 kinase. An in vitro kinase assay, using immunoprecipitated E2F6 as a substrate and recombinant Chk1, confirmed that Chk1 can directly phosphorylate E2F6 in vitro ( Figure 4A ). Next we sought to identify the specific E2F6 site(s) targeted by Chk1. A deletion mutant lacking the first N-terminal 60 amino acids identified that Chk1-dependent phosphorylation of E2F6 is mainly in the first 60 amino acids ( Figure S4B ). In the first N-terminal 60 amino acids, two serine residues, Ser 12 and Ser 52, conform to a potential Chk1 consensus (Figure 4B) , and an in vitro kinase assay peptide array identified both sites as Chk1 targets. Whereas Ser12 appeared to be the main target site on the basis of in vitro kinase analysis of the single site mutants, the double-site mutant (E2F6 S12/52A ) greatly reduces phosphorylation of the E2F6 protein by Chk1 in vitro ( Figure 4C ), suggesting that both sites can be targeted by Chk1. Phosphorylation of Ser12 upon HU treatment was also identified in vivo by a phospho-Ser12-specific antibody ( Figure 4D ) and by mass spectrometric analysis (data not shown). Inhibition of Chk1 with UCN01 reduces the extent of E2F6 phosphorylation on Ser12, confirming the role of Chk1 in the regulation of endogenous E2F6 ( Figure S4C) .
To determine the role of phosphorylation of E2F6 at Ser12/ 52 in response to replication stress, we assessed binding of E2F6 to E2F-regulated promoters and expression of E2F genes after HU treatment in synchronized cells expressing either ectopic wild-type E2F6, E2F6 S12/52A , or vector alone ( Figure 4E ). Maximal binding of wild-type E2F6 to promoters during S phase is reduced upon HU treatment ( Figure 4F ), as previously shown ( Figure 3B ). However, E2F6 S12/52A does not appear to dissociate from promoters after HU addition, compared to the untreated samples ( Figure 4F ). The persistence of E2F6 S12/52A at promoters correlates with reduced expression of E2F transcripts in response to checkpoint activation ( Figure S4D ). Altogether, these results indicate that Chk1 phosphorylates E2F6 at Ser12 and Ser52 to regulate its function in response to DNA replication stress.
Derepressing G1/S Transcription via E2F6 Inactivation Limits DNA Damage upon Replication Stress
It has been well established that, in response to replication stress, checkpoint activation is required to stabilize replication forks [31] and activate other mechanisms to avoid the accumulation of DNA damage [11, 32] . When the checkpoint is inhibited, either by depletion of Chk1 or by treatment with inhibitors, increased DNA damage is detected. We therefore aimed to establish whether the activation of G1/S transcription was involved in limiting DNA damage in checkpoint-compromised cells exposed to replication stress. We reasoned that if inactivation of E2F6 by the checkpoint is required to prevent DNA damage, then ectopic expression of the checkpointinsensitive E2F6 12/52 mutant should increase the extent of DNA damage after replication stress. Cells expressing doxycycline-inducible wild-type E2F6 or E2F6 12/52 were treated with a low concentration of HU for 24 hr in the presence of doxycycline, and DNA damage was analyzed by western blot with anti-gamma-H2AX antibodies ( Figure 4G ). HU alone induces a barely detectable increase of gamma-H2AX, which could also be partially explained by the cell synchronization occurring upon HU treatment. Upon HU treatment, cells overexpressing wild-type E2F6 (2 and 4 mg/ml Doxy) show a slight increase in gamma-H2AX compared to noninduced conditions (0 Doxy). Strikingly, the extent of H2AX phosphorylation is greatly increased by overexpression of the checkpoint-insensitive E2F6
12/52 mutant (compare lane 9 with lanes 10 and 11), suggesting that DNA damage occurs mostly when cells cannot activate a proper transcriptional response to replication stress. Altogether, these data support a role for checkpointdependent inactivation of E2F6 in preventing DNA damage after replication stress.
Inactivation of E2F6 Is Important for Cell Survival during Replication Stress
Our data point to an important role for Chk1 in regulating E2F6-dependent G1/S transcription. Next we investigated the biological significance of Chk1's ability to keep G1/S transcription on. Since many G1/S genes encode proteins involved in DNA replication and repair [25, 33] , we assessed whether G1/S transcriptional induction is an important part of the checkpoint 1% FCS with the reported siRNA, and after 48-72 hr serum was added. At the indicated time points, RNA was extracted and the relative RNA abundance was calculated as previously described. Average 6 SD is shown (n = 3). Black lines, E2F6 siRNA; gray lines, control siRNA. Red boxes mark the times when checkpoint-dependent activation of these transcripts was observed in Figure 1 . See also Figures S2 and S3 and Table S4 and  Table S5. response for cell viability. CHK1 is an essential gene whose inhibition causes cell death due to DNA damage accumulation during S phase [34, 35] . We reasoned that if Chk1-dependent inactivation of E2F6 is an important part of the checkpoint response, knockdown of E2F6 in cells inhibited for Chk1 function should partially rescue cell death. Synchronized cells transfected with control or E2F6 siRNA were treated with Chk1 inhibitor UCN01, HU, or both and were analyzed for cell viability. We observe that depletion of E2F6 suppresses about 40% of the cell death induced by Chk1 inactivation, as assessed by accumulation of cells with a sub-G1 DNA content and caspase 3 cleavage (Figures 5A and S5A ). This indicates that inactivation of E2F6 and, thereby, activation of G1/S transcription is important for cell survival in response to replication stress as a result of checkpoint activation. Based on this, we reasoned that the opposite, an inability to inactivate E2F6 and activate G1/S transcription, would be detrimental to cells upon replication stress. To investigate this we analyzed the Table S6. survival of cells where E2F6 was overexpressed, compromising checkpoint inactivation, in a clonogenic survival assay. HEK293 T-Rex cells were treated with HU for 24 hr in the presence of various concentrations of doxycycline to induce E2F6 expression ( Figure 5B ), after which they were diluted and allowed to form colonies. Induction of E2F6 in these cells strongly reduces cell survival after HU treatment ( Figures  5B and 5C ) while increasing the extent of DNA damage compared to HU alone ( Figure S5B ). Collectively, these data support an important role for inactivation of E2F6 and thereby activation of G1/S transcription for cell survival after replication stress.
Discussion
In this study we show that, in response to DNA replication stress, the regular cell-cycle transcriptional program is maintained at high levels in a Chk1-dependent manner, and we have uncovered the mechanisms governing such transcriptional upregulation. We show that E2F6, a repressor of E2F-dependent G1/S transcription, replaces the activating E2Fs at promoters to repress transcription in cells progressing into S phase. When cells experience replication stress, the DNA replication checkpoint kinase Chk1, which is activated by ATR, phosphorylates E2F6, leading to its dissociation from promoters. This promotes E2F-dependent transcription, including that of those genes involved in DNA repair and nucleotide synthesis, which mediates cell survival by preventing genomic instability and cell death.
There might be several reasons to maintain high expression levels of the cell-cycle transcriptional program in response to replication stress. For one, many of the genes regulated during G1/S encode proteins required for DNA replication, including DNA polymerases and enzymes involved in the production of dNTPs. One reason for keeping G1/S transcription on during an intra-S-phase arrest, therefore, might be to maintain the level of proteins required to complete replication once the checkpoint arrest has been relieved. In addition, many of the genes of the G1/S transcriptome have important roles in the stabilization of stalled replication forks and in DNA repair; hence, their presence is required to prevent genomic instability. Chk1 itself is encoded by a G1/S gene and, because the activation of the checkpoint has been reported to increase Chk1 protein turnover [36] , we speculate that enhanced Chk1 expression could be required to maintain an efficient checkpoint. Finally, maintaining the expression of genes that are required for subsequent cell-cycle events, other than DNA replication, prepares the cell for resuming cell-cycle progression once the checkpoint is turned off.
This study reveals that the DNA replication checkpoint interferes with the E2F6-dependent negative feedback loop to maintain high levels of G1/S transcription in response to replication stress. Other E2F family members might be involved in the checkpoint transcriptional response. For instance, the activating E2Fs (E2F1, E2F2, and E2F3) are required for the expression of E2F target genes and might therefore also be the target of checkpoint regulation to maintain high levels of expression. E2F7 and E2F8 have been proposed to inactivate G1/S transcription during S phase, and recent studies have shown that the binding of those factors to the E2F1 promoter is positively regulated by the DNA damage checkpoint in order to reduce E2F1-dependent apoptosis [37, 38] . Consequently, depletion or deletion of both E2F7 and E2F8 increases DNAdamage-induced cell death. It is likely that the various E2Fs involved in G1/S transcription regulation might be affected in a different way in response to particular forms of stress. This would allow cells to diversify their response to different stimuli and to titrate the biological response to the level and nature of the insult.
Activation of the regular periodic transcriptional program by replication stress has been demonstrated in Schizosaccharomyces pombe and in Saccharomyces cerevisiae [39] [40] [41] . However, the E2F family of transcription factors and their coregulators, the pocket proteins, share no sequence homology with their yeast counterparts. Remarkably, our study reveals that the simple yet elegant mechanism by which checkpoint activation can override the regular periodic transcriptional program is conserved from yeast to humans; the effector checkpoint protein kinase directly interferes with the autoregulatory negative feedback loop involved in turning off G1/S transcription. This illustrates the importance of both the wiring of these transcriptional networks and the capacity of those networks to be rewired in cells responding to stress.
A role for the activator E2F, E2F1, in the DNA damage checkpoint response has been well established [18] [19] [20] [21] 42] . Interestingly, in such studies, DNA damage induces E2F1 activity and thereby the expression of specific proapoptotic genes. These targets do not normally have a role in the cell cycle and are not part of the E2F-dependent cell-cycle transcriptional program. Furthermore, this mechanism of regulation depends on transcriptional induction, while the seemingly modest upregulation of G1/S transcripts in response to replication stress results from the checkpoint merely maintaining peak expression by interfering with timely repression, rather than by inducing transcription. We speculate that since the G1/S transcriptional network comprises a large number of dosage-sensitive coregulated genes, this particular mechanism of regulation allows for a controlled high level of expression within the ''normal'' range. Therefore, this seemingly modest upregulation represents the difference between ''on'' and ''off'' of G1/S genes expression during the cell cycle, which is undoubtedly of biological significance. In addition, our study highlights an inherent difference between the DNA replication and DNA damage checkpoint responses, showing an intrinsically different role for E2F1 in response to DNA replication stress by promoting genome stability and survival rather than cell death. This emphasizes the contrasts between the diverse cellular responses to specific genotoxic stresses. Whereas very toxic DNA damage lesions such as doublestrand breaks can induce a strong apoptotic response, replication stress causes replication fork stalling, which only results in DNA damage when forks collapse after prolonged stress or in the absence of an efficient checkpoint [43] . Therefore, the cellular response to replication stress aims to stabilize replication forks and prevent DNA damage, at least temporarily, rather than induce cell death.
We show that E2F6 antagonizes the function of E2F1 and depletion of E2F6 reduces the toxic effect of Chk1 inactivation, while overexpression of E2F6 reduces the survival of HUtreated cells with a concomitant increase in DNA damage. Collectively, our data support an important role for the expression of G1/S genes in cells responding to DNA replication stress, in addition to the well-established role in cell-cycle progression. They highlight a critical role for this transcriptional response in preventing DNA damage and possible associated genomic instability, key events in oncogenic transformation. Future research will have to establish which E2F targets are of particular importance in responding to replication stress to prevent DNA damage and ensure cell survival.
Experimental Procedures
Cell Culture and Transfection T98G (p53 mutated) cells (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum (FCS) supplemented with penicillin and streptomycin (Invitrogen). Synchronization was achieved by 48-72 hr culture in DMEM with 0.1% FCS and release in DMEM with 10% FCS. HU was added as indicated to serum-synchronized cells 15 hr after release. Transfection of siRNA was performed with Oligofectamine (Invitrogen).
ChIP and Real-Time PCR ChIP of synchronized cells was performed as previously reported [30] . RNA was isolated with the RNeasy kit from QIAGEN, and qRT-PCR was performed with a Eurogentec kit. Kinase Assays HEK293 cells were transfected with pcDNA myc E2F6 [44] or pcDNA3 HA-E2F6 wild-type [45] , the recombinant proteins were purified by immunoprecipitation, and the kinase assay was performed as previously described with recombinant Chk1 (Activemotif).
See the Supplemental Experimental Procedures for additional details.
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